Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Pasithea Therapeutics Cor...

    NASDAQ: KTTA · Real-Time Price · USD
    0.73
    -0.00 (-0.63%)
    At close: Jul 02, 2025, 9:47 AM

    Pasithea Therapeutics Statistics

    Share Statistics

    Pasithea Therapeutics has 7.44M shares outstanding. The number of shares has increased by 612.93% in one year.

    Shares Outstanding

    n/a
    		 7.44M

    Shares Change (YoY)

    n/a
    		 612.93%

    Shares Change (QoQ)

    n/a
    		 175.15%

    Owned by Institutions (%)

    n/a
    		 0.99%

    Shares Floating

    n/a
    		 6.84M

    Failed to Deliver (FTD) Shares

    n/a
    		 173

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 190.82K, so 2.56% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 190.82K

    Short % of Shares Out

    n/a
    		 2.56%

    Short % of Float

    n/a
    		 2.64%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -0.25 and the forward PE ratio is null. Pasithea Therapeutics's PEG ratio is -0.88.

    PE Ratio

    n/a
    		 -0.25

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 0

    P/FCF Ratio

    n/a
    		 0

    PEG Ratio

    n/a
    		 -0.88
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Pasithea Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 6.58, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 6.58

    Quick Ratio

    n/a
    		 6.58

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-3,476,146

    Employee Count

    n/a
    		 4

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -85.85% in the last 52 weeks. The beta is 0.34, so Pasithea Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.34

    52-Week Price Change

    n/a
    		 -85.85%

    50-Day Moving Average

    n/a
    		 1.03

    200-Day Moving Average

    n/a
    		 2.31

    Relative Strength Index (RSI)

    n/a
    		 35.91

    Average Volume (20 Days)

    n/a
    		 6,377,095

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 -649.03K

    Operating Income

    n/a
    		 -14.25M

    Net Income

    n/a
    		 -13.9M

    EBITDA

    n/a
    		 -13.26M

    EBIT

    n/a
    		 -13.9M

    Earnings Per Share (EPS)

    n/a
    		 -12.69
    Full Income Statement

    Balance Sheet

    The company has 6.92M in cash and 0 in debt, giving a net cash position of 6.92M.

    Cash & Cash Equivalents

    n/a
    		 6.92M

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 -49.58B

    Total Assets

    n/a
    		 14.66B

    Working Capital

    n/a
    		 4.53B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -13.92B and capital expenditures 0, giving a free cash flow of -13.92B.

    Operating Cash Flow

    n/a
    		 -13.92B

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -13.92B

    FCF Per Share

    n/a
    		 -12702.92
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    KTTA does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for KTTA.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jan 2, 2024. It was a backward split with a ratio of 1:20.

    Last Split Date

    n/a
    		 Jan 2, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:20

    Scores

    Altman Z-Score

    n/a
    		 -4.71

    Piotroski F-Score

    n/a
    		 0

    Add to Watchlist